US 10758613
Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10758613 (Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K31/337